Clorox Company (The) (NYSE:CLX) Given “Hold” Rating at Jefferies Group LLC

Clorox Company (The) (NYSE:CLX)‘s stock had its “hold” rating restated by equities researchers at Jefferies Group LLC in a research note issued to investors on Friday, October 6th. They presently have a $132.00 price objective on the stock, down from their previous price objective of $137.00. Jefferies Group LLC’s price target suggests a potential upside of 0.14% from the stock’s current price. Jefferies Group also issued estimates for Clorox Company (The)’s Q1 2018 earnings at $1.39 EPS, Q2 2018 earnings at $1.32 EPS, Q3 2018 earnings at $1.22 EPS, FY2018 earnings at $5.55 EPS and FY2020 earnings at $6.25 EPS.

CLX has been the topic of a number of other research reports. Royal Bank Of Canada restated a “hold” rating and set a $115.00 price target on shares of Clorox Company (The) in a research note on Wednesday, August 2nd. Zacks Investment Research downgraded Clorox Company (The) from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. BidaskClub downgraded Clorox Company (The) from a “sell” rating to a “strong sell” rating in a research note on Monday, July 24th. BMO Capital Markets restated an “outperform” rating on shares of Clorox Company (The) in a research note on Tuesday, September 12th. Finally, Barclays PLC reiterated an “equal weight” rating and issued a $136.00 target price (down from $140.00) on shares of Clorox Company (The) in a research note on Friday, August 4th. Three research analysts have rated the stock with a sell rating, nine have issued a hold rating and two have issued a buy rating to the stock. The company presently has an average rating of “Hold” and an average target price of $127.39.

Shares of Clorox Company (NYSE:CLX) opened at 131.81 on Friday. The company’s 50 day moving average price is $133.27 and its 200-day moving average price is $134.31. The firm has a market cap of $17.01 billion, a P/E ratio of 24.71 and a beta of 0.40. Clorox Company has a 12-month low of $111.24 and a 12-month high of $141.76.

Clorox Company (The) (NYSE:CLX) last released its quarterly earnings results on Thursday, August 3rd. The company reported $1.53 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.49 by $0.04. The firm had revenue of $1.65 billion for the quarter, compared to the consensus estimate of $1.65 billion. Clorox Company (The) had a return on equity of 190.67% and a net margin of 11.74%. The firm’s quarterly revenue was up 2.9% compared to the same quarter last year. During the same quarter last year, the business posted $1.30 EPS. On average, equities research analysts anticipate that Clorox Company will post $5.63 EPS for the current year.

COPYRIGHT VIOLATION NOTICE: This story was first posted by BBNS and is the property of of BBNS. If you are accessing this story on another site, it was illegally stolen and reposted in violation of U.S. & international copyright & trademark law. The legal version of this story can be viewed at https://baseballnewssource.com/markets/jefferies-group-llc-reiterates-hold-rating-for-clorox-company-the-clx/1697773.html.

In other news, SVP Jon M. Balousek sold 9,223 shares of the firm’s stock in a transaction that occurred on Wednesday, August 23rd. The stock was sold at an average price of $138.87, for a total value of $1,280,798.01. Following the completion of the sale, the senior vice president now directly owns 20,614 shares of the company’s stock, valued at approximately $2,862,666.18. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP James E. Foster sold 9,861 shares of the firm’s stock in a transaction that occurred on Wednesday, August 23rd. The shares were sold at an average price of $138.51, for a total value of $1,365,847.11. Following the completion of the sale, the executive vice president now directly owns 22,069 shares of the company’s stock, valued at $3,056,777.19. The disclosure for this sale can be found here. Insiders sold a total of 21,242 shares of company stock valued at $2,944,449 over the last three months. Insiders own 1.00% of the company’s stock.

Several institutional investors and hedge funds have recently bought and sold shares of CLX. Vanguard Group Inc. raised its holdings in Clorox Company (The) by 2.6% during the second quarter. Vanguard Group Inc. now owns 14,534,634 shares of the company’s stock worth $1,936,595,000 after purchasing an additional 369,918 shares during the last quarter. BlackRock Inc. raised its holdings in Clorox Company (The) by 1,402.2% during the first quarter. BlackRock Inc. now owns 10,390,206 shares of the company’s stock worth $1,400,912,000 after purchasing an additional 9,698,542 shares during the last quarter. State Street Corp raised its holdings in Clorox Company (The) by 2.2% during the first quarter. State Street Corp now owns 7,648,999 shares of the company’s stock worth $1,031,304,000 after purchasing an additional 167,689 shares during the last quarter. Wells Fargo & Company MN raised its holdings in Clorox Company (The) by 5.3% during the second quarter. Wells Fargo & Company MN now owns 4,412,600 shares of the company’s stock worth $587,934,000 after purchasing an additional 221,168 shares during the last quarter. Finally, Valueinvest Asset Management S.A. raised its holdings in Clorox Company (The) by 6.9% during the first quarter. Valueinvest Asset Management S.A. now owns 1,580,400 shares of the company’s stock worth $213,085,000 after purchasing an additional 102,300 shares during the last quarter. 71.22% of the stock is owned by institutional investors and hedge funds.

Clorox Company (The) Company Profile

The Clorox Company is a manufacturer and marketer of consumer and professional products. The Company sells its products primarily through mass retail outlets, e-commerce channels, wholesale distributors and medical supply distributors. The Company operates through four segments: Cleaning, Household, Lifestyle and International.

Analyst Recommendations for Clorox Company (The) (NYSE:CLX)

Receive News & Ratings for Clorox Company (The) Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox Company (The) and related companies with our FREE daily email newsletter.

 


Latest News

Houston Astros Relying on Justin Verlander to Save Their Season
Houston Astros Relying on Justin Verlander to Save Their Season
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Clayton Kershaw Gets Chance to Pitch LA into Fall Classic
Aaron Judge and Gary Sanchez Have Break Out Games
Aaron Judge and Gary Sanchez Have Break Out Games
Justin Turner Joining Postseason Legends
Justin Turner Joining Postseason Legends
PED Use Cost Alex Rodriguez Millions and His Reputation
PED Use Cost Alex Rodriguez Millions and His Reputation
Yankees to Send Masahiro Tanaka Against Astros in Game 1
Yankees to Send Masahiro Tanaka Against Astros in Game 1


Leave a Reply

 
© 2006-2017 BBNS.